Cargando…
Hypothesis for the management and treatment of the COVID-19-induced acute respiratory distress syndrome and lung injury using mesenchymal stem cell-derived exosomes
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a member of the coronaviridae that causes respiratory disorders. After infection, large amounts of inflammatory cytokines are secreted, known as the cytokine storm. These cytokines can cause pulmonary damage induced by inflammation resu...
Autores principales: | Taghavi-Farahabadi, Mahsa, Mahmoudi, Mohammad, Soudi, Sara, Hashemi, Seyed Mahmoud |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7242964/ https://www.ncbi.nlm.nih.gov/pubmed/32562911 http://dx.doi.org/10.1016/j.mehy.2020.109865 |
Ejemplares similares
-
Natural killer cells and their exosomes in viral infections and related therapeutic approaches: where are we?
por: Razizadeh, Mohammad Hossein, et al.
Publicado: (2023) -
Immune cells-derived exosomes function as a double-edged sword: role in disease progression and their therapeutic applications
por: Hazrati, Ali, et al.
Publicado: (2022) -
Mesenchymal stem cell therapies for COVID-19: Current status and mechanism of action
por: Sadeghi, Somaye, et al.
Publicado: (2020) -
Mesenchymal Stromal/Stem Cells and Their Extracellular Vesicles Application in Acute and Chronic Inflammatory Liver Diseases: Emphasizing on the Anti-Fibrotic and Immunomodulatory Mechanisms
por: Hazrati, Ali, et al.
Publicado: (2022) -
Effect of mesenchymal stem cell‐derived exosomes on the induction of mouse tolerogenic dendritic cells
por: Shahir, Mehri, et al.
Publicado: (2020)